Abate As Industries Ltd

Abate As Industries Ltd, a micro-cap player in the hospital sector, has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. Despite a challenging year-to-date performance with a stock return of -44.9% compared to the Sensex's -7.97%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more compelling entry point for investors seeking value in the healthcare space.

Abate As Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Abate As Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Abate As Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

For the second consecutive session, Abate As Industries Ltd has seen its share price decline sharply, hitting a fresh 52-week low of Rs 8 on 29 Jun 2026. This drop comes despite a broader market that has been relatively resilient, with the Sensex gaining 3.83% over the past three weeks.

Abate As Industries Ltd’s stock price declined to a fresh 52-week low of Rs.8.76 on 25 June 2026, marking a significant milestone in its recent trading performance. This new low reflects ongoing challenges faced by the company within the hospital sector, despite some positive financial indicators in recent quarters.

Abate As Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Abate As Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Abate As Industries Ltd, a micro-cap player in the hospital sector, has witnessed a significant shift in its valuation parameters, moving from a very expensive to a very attractive price range. This change is underscored by a notable improvement in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the stock as a compelling consideration for investors seeking value in a volatile market environment.

Abate As Industries Ltd., a micro-cap hospital operator with a market capitalisation of ₹158.00 crores, reported a consolidated net profit of ₹2.93 crores for Q4 FY26, marking a remarkable 146.22% year-on-year surge from ₹1.19 crores in Q4 FY25. However, the quarter-on-quarter performance revealed a 4.25% decline from ₹3.06 crores in Q3 FY26, signalling potential momentum challenges. The stock, trading at ₹10.39 as of May 29, 2026, has delivered a modest 2.87% gain in the latest trading session but remains deeply underwater on a year-to-date basis, down 40.63%.

Abate As Industries Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing fundamental weaknesses. The hospital sector micro-cap’s recent performance and financial metrics reveal a complex picture, with positive quarterly results and rising promoter confidence contrasting with persistent operating losses and valuation concerns.

Abate As Industries Ltd, a micro-cap player in the hospital sector, has seen its investment rating downgraded from Sell to Strong Sell as of 22 May 2026. This shift reflects deteriorating technical indicators and persistent fundamental weaknesses despite some recent positive financial results and rising promoter confidence.

Abate As Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

While the broader market indices showed resilience with the Sensex gaining 0.33% today, Abate As Industries Ltd succumbed to selling pressure, hitting a fresh 52-week low of Rs 9.26. This decline comes amid a two-day losing streak that has dragged the stock down by 3.66%, underperforming its sector by 2.65% on the day.

Despite a broader market rally, Abate As Industries Ltd has slipped to a fresh 52-week low of Rs 9.35 on 12 Jun 2026, marking a significant divergence from the overall market trend.

Abate As Industries Ltd, a micro-cap player in the hospital sector, has seen its investment rating upgraded from Strong Sell to Sell as of 11 May 2026, driven primarily by a shift in technical indicators. Despite this upgrade, the company continues to face significant challenges in valuation and financial strength, underscoring a cautious outlook for investors.

Abate As Industries Ltd, a micro-cap player in the hospital sector, has seen its investment rating downgraded from Sell to Strong Sell as of 4 May 2026. This revision reflects deteriorating technical indicators, expensive valuation metrics, and weak long-term fundamentals despite recent positive quarterly financial results and rising promoter confidence.